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AbstrACt
Introduction Persistent and distressing somatic 
symptoms are common in younger age cohorts such 
as university students. However, the majority does not 
receive adequate psychosocial care. Internet-based and 
mobile-based interventions may represent low threshold 
and effective extensions to reduce somatic and associated 
mental symptom severity. The planned study aims to 
investigate the feasibility and efficacy of an internet-
based intervention in reducing somatic and psychological 
symptoms in an international population of university 
students with somatic symptom burden.
Methods and analysis This parallel two-armed 
randomised controlled trial evaluates an 8-week guided 
intervention, including web-based consecutive modules 
based on cognitive behavioural therapy (CBT) principles 
against a waitlist control group. Guidance will be provided 
by trained psychologists with weekly written supportive 
feedback. As part of the ‘Studicare’ project, the present 
study aims to recruit n=154 university students indicating 
somatic symptom burden at baseline in German-speaking 
universities. Self-report assessments will take place at 
baseline and after intervention completion (8, 16 weeks 
after randomisation). The primary outcome will be the 
severity of somatic symptoms and associated mental 
distress. Secondary outcomes include depression, (health) 
anxiety, disability, intervention satisfaction and adherence.
Ethics and dissemination Ethics approval has been 
granted. Results from this study will be published in 
peer-reviewed journals and presented at international 
conferences.
trial registration number DRKS00014375; Pre-results.
IntroduCtIon 
The experience of somatic symptom distress 
represents the hallmark of a number of clin-
ical conditions such as somatoform disorders 
(Diagnostic and Statistical Manual of Mental 
Disorders (DSM)-IV, 10th revision of the Inter-
national Statistical Classification of Diseases 
and Related Health Problems, ICD-10), the 
recently adapted diagnoses under the term 
somatic symptom disorders (DSM-5) as well 
as functional somatic syndromes (eg, fibromy-
algia, irritable bowel syndrome). In all these 
conditions, the experience of somatic symp-
toms is commonly associated with high levels 
of impairment in quality of life, psychological 
distress or increased healthcare utilisation.1 2 
Somatic symptom disorders (SSDs) are among 
the most prevalent disorders in primary care 
patients.3 Eventually, this condition has been 
associated with an elevated risk for chronic 
manifestation and comorbid mental disor-
ders,4 work loss5 or early retirement.6 
Regarding the development of chronic 
somatic symptoms, recent integrative models 
highlight the role of cognitive processes 
beyond somatic pathologies. According to 
Brown,7 two attention systems regulate the 
experience and consequences of physical 
complaints: first, afferent somatic sensations 
are selected automatically based on heuris-
tics from previous experiences (eg, illness, 
emotional distress). Second, intentional 
attentional processes lead to a chronic focus 
on these sensations, which accelerates somatic 
symptom perception, increases arousal and 
strengths and limitations of this study
 ► First internet-based guided cognitive behavioural 
therapy (CBT) for young adults with somatic symp-
tom distress.
 ► International sample of German-speaking university 
students will be recruited.
 ► Challenges of this trial include the diverse target 
group and somatic conditions.
 ► Strong theoretical and clinical foundation through 
established CBT manual.
 ► Therapeutic alliance and side effects will be 
monitored.
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thus modulates the sensitivity of the primary attention 
system. Similarly, van den Bergh et al8 highlight the proba-
bilistic and inferential nature of information processing of 
somatic sensations. With regard to learning mechanisms, 
a series of experiments could furthermore demonstrate 
that somatic symptoms can be conditioned without pres-
ence of any somatic pathology, in which negative affect 
plays a central role.9 This interaction of physiological and 
psychological processes has important implications for 
the treatment of chronic somatic symptoms. Thus, treat-
ment guidelines recommend a biopsychosocial rationale, 
combining medical care and psychosocial interventions 
such as psychotherapy to promote coping mechanism, 
functioning and quality of life.10
A growing body of evidence suggests the effectiveness 
of cognitive behavioural therapy (CBT) in SSDs with 
small-to-medium effect sizes,11 12 while the evidence for 
peripheral interventions (eg, medication, injections, 
operations) is controversial.13 14 Furthermore, self-help 
interventions have been shown to be effective in various 
somatoform disorders.15
However, Wittchen and Jacobi16 estimate that only 40% 
of patients with severe SSDs receive adequate psycho-
therapeutic care, which represents the second highest 
rate of undertreatment of mental disorders in Germany. 
Regarding the academic context, only 16.4% of univer-
sity students with mental disorders in 21 countries receive 
adequate healthcare treatment.17 Beyond structural 
limitations regarding healthcare resources and treatment 
allocation, challenges of psychosocial care include long 
waiting times,18 time-consuming and distressing treat-
ment seeking,19 somatic-dominated health models, fear 
of stigmatisation,20 unfavourable treatment experiences 
and expectations in patients21 and health professionals’ 
negative attitudes towards patients with somatoform 
disorders.22
In an effort to reduce the threshold to the access to 
healthcare instruments, internet-based and mobile-based 
interventions (IMIs) have been developed extensively 
within the last decade. Advantages of IMIs include wide-
spread accessibility, local and temporal flexibility, cost-effec-
tiveness23 and low threshold for psychological issues.24 In 
this regard, various studies show that IMIs are acceptable in 
university students.25 26 IMIs may vary regarding technical 
implementation (eg, web-based or mobile-based), inter-
vention strategy and localisation in the healthcare process 
(eg, prevention, stand-alone interventions, aftercare) or 
the amount of human guidance.27 Meta-analytic evidence 
indicates the efficacy of IMIs for various mental disorders 
with effect sizes ranging from standardised mean differ-
ence (SMD)=0.31 (n=16) for eating disorders to SMD=1.52 
(n=6) for panic disorders, with higher effect sizes for guided 
interventions.28 Further evidence suggests the efficacy of 
internet interventions in university students, with medium-
to-high effect sizes for common mental disorders such as 
depression or anxiety29 and stress-reducing interventions.30
Beyond the academic context, evidence on the effi-
cacy of IMIs in chronic somatic conditions shows a wide 
range of effects depending on the condition under study. 
Meta-analytic evidence by van Beugen et al31 points to an 
overall small effect size for psychological outcomes (eg, 
depressive symptoms, n=15, SMD=0.21, 95% CI: 0.08 
to 0.34) and mostly positive effects on disease-specific 
physical outcomes (59%, n=10/17 studies in favour of 
internet-based CBT (iCBT)). Existing evidence mostly 
refers to functional somatic syndromes.32–34 Here, the 
evidence is promising for irritable bowel syndrome 
(IBS). For example, subgroup analyses of six web-based 
self-help interventions by Liegl et al35 yielded a large 
pooled effect size (SMD=1.01; 95% CI: 0.78 to 1.23). 
The evidence base for the effectiveness of IMIs in fibro-
myalgia is less profound but indicates a positive effect 
of IMIs.36 Furthermore, a series of studies by Hedman 
et al with hypochondriac patients could demonstrate 
a large effect (SMD=1.62, 95% CI: 1.10 to 2.10) of a 
3-month web-based CBT compared with an attention 
control group.37 For chronic pain, a recent meta-anal-
ysis of 11 studies by Macea et al38 found a small effect 
of web-based CBT (SMD=0.29, 95% CI: 0.15 to 0.42). 
In chronic physical conditions, reviews indicate a lower 
efficacy of IMIs for distress or psychological outcomes 
than for somatic symptoms.32 33 Above that, studies 
investigating IMIs for SSD are scarce: Hedman et al39 
investigated a guided iCBT in a mixed sample including 
participants with SSD (n=114/86.4%) and yielded large 
effect on health anxiety (SMD=1.27, 95% CI: 0.72 to 
1.79) but not for depression in comparison to a waitlist 
control group (WLCG). Similarly, an Australian study 
testing a guided iCBT against a psychoeducation control 
group found high effects on the reduction of health 
anxiety in a sample including participants with SSD.40 
However, these studies focused on health anxiety and 
as such did not assess the level of somatisation, limiting 
their generalisability to SSDs.
Thus, SSDs or somatoform syndromes remain an insuf-
ficiently studied research area in internet interventions, 
particularly in younger age cohorts, where elevated 
somatisation and elevated risk for the development 
of SSDs has been observed.41 42 University students, in 
particular, show a higher risk of developing mental disor-
ders than non-students, with increasing rates of severe 
mental health issues17 43 and reduced uptake of medical 
services.44 A survey by Bailer et al45 found that 9.1% of 
university students of a major German university fulfilled 
the criteria for a subclinical somatoform syndrome. Also, 
SSDs represent the second most prevalent mental disor-
ders (6.6%) in German university students according to 
an insurance report.46 Longitudinal data also indicate 
that stress factors contribute to the development and 
persistence of mental disorders in academia47 48 and that 
these have been associated with reduced academic func-
tioning49 or university attrition.48 Together, these reports 
underline the importance of effective and accessible 
healthcare instruments in academia.
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objectives
This trial thus aims to evaluate the feasibility and efficacy 
of a guided iCBT, based on an established short-term CBT 
manual,50 as a stand-alone transdiagnostic intervention 
for somatic symptoms and related distress (internet-based 
intervention for somatic symptoms (iSOMA)) in an adult 
population of university students. The present study is 
embedded in the project ‘studicare’ and hosted on the 
corresponding platform www. studicare. com. Studicare 
combines IMIs for various mental and behavioural issues 
(eg, procrastination, stress, mindfulness, social and test 
anxiety, physical activity, internet addiction, depression) 
to promote mental health in graduate students. It is 
expected that:
1. iSOMA is effective in reducing the severity of somatic 
symptoms and related distress compared with a WLCG.
2. Compared with WLCG, iSOMA is superior in reducing 
comorbid mental symptoms (depression, anxiety and 
health anxiety) and in improving the level of function-
ing and attitudes towards psychotherapy.
Furthermore, it will be explored, if the efficacy of 
iSOMA is moderated/mediated by somatosensory ampli-
fication, emotional reactivity, expectations towards the 
internet intervention, therapeutic alliance as well as 
medical and demographic characteristics. The influence 
of acceptability and intervention adherence on clinical 
outcomes will be examined. Possible adverse events and 
side effects will be monitored. Also, outcomes will be eval-
uated exploratively by comparing two levels of therapist 
guidance (regular feedback vs feedback on demand) as 
applied in the two intervention arms (figure 1) and the 
effect of optional short text messages.
MEthods
study design
This project is a two-armed, randomised controlled study 
of paralleled design comparing the efficacy of an iCBT 
with a WLCG. Both conditions will have unrestricted 
access to treatment as usual. The trial will be reported in 
accordance with the Consolidated Standards of Reporting 
Trials guidelines for randomised controlled trials51 and 
recommendations for internet intervention trials.52
Eligibility criteria
In order to be eligible for the study, participants need to 
be (a) aged ≥18 years, (b) enrolled university students 
with (c) internet access and (d) sufficient knowledge of 
the German language, who (e) score in a clinical range of 
somatisation, as indicated by a value of ≥4 in the Patient 
Figure 1 Flow chart of inclusion and study procedure.  iSOMA, internet-based training for somatic symptoms; PHQ-
15, Patient Health Questionnaire; WLCG, waitlist control group.
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Health Questionnaire (PHQ-15),53 which has recently 
been shown to be a sensitive cut-off criterion for the 
detection of somatic symptom disorder.54 Furthermore, 
(f) participants will need to provide a signed copy of the 
informed consent form via email or postal.
setting/recruitment
Recruitment has started in August 2018 and will continue 
until the targeted sample size has been reached. Partic-
ipants from Germany, Swiss or Austrian universities are 
recruited consecutively through online resources (eg, 
studicare platform, study web portal, social networks), 
newspapers or university press reports and academic 
institutions for student health (eg, student counselling, 
occupational health management, college sport, etc). 
Recruiting measures will be applied adaptively depending 
on the inclusion rate. At the time of this protocol, 15 
universities were already associated with studicare (see 
http://www. studicare. com/ studicare- universitaeten), 
sending healthcare information including IMI offers to 
their students on a regular basis throughout study terms. 
Participants can apply via email and receive screening 
questionnaires to assess eligibility. Eligible individuals 
providing their informed consent are then contacted by 
the study team via email including further information 
and a link referring to the internet intervention. Partic-
ipants are informed that the intervention under study 
does not replace any medical diagnosis or therapy and 
are recommended to seek medical counselling in case of 
unclear health conditions.
Patient and public involvement
Patients and the public were not involved in the design 
of the study.
randomisation
Eligible participants will be randomly allocated to either 
the internet intervention or WLCG. Randomisation and 
allocation will be performed by an independent person 
blinded to investigators and all processes within the inter-
vention. For randomisation, an automated, web-based 
programme (www.  sealedenvelope. com) will be used, with 
an allocation ratio of 1:1 and permuted block sizes (2, 4, 
6). Allocation concealment will be ensured, as the service 
will not release the randomisation code until the partici-
pant has been recruited into the trial, which takes place 
after completion of the baseline measurement. Within 
the course of the study, neither participants nor the 
e-coaches can be blinded to allocation due to the nature 
of the intervention. An employee outside the research 
team will feed data into the computer in separate data-
sheets so that the researchers can analyse data without 
having access to information about the allocation.
Intervention
Intervention condition
The intervention was adapted from an established CBT 
rationale for medically unexplained or somatoform symp-
toms50 and regarding the study design and intervention 
structure from previous trials of the research group.55 56 The 
intervention consists of seven, weekly modules following a 
short introduction. The duration of the main modules is 
approximately 45–60 min. After completion, all modules 
are unlocked for repeated view. Each module includes 
psychoeducation, behavioural experiments, exercises 
and assignments, questions and interactive elements (eg, 
quizzes, conditional content) via text, audio or video. 
The modules start with a reflection on the assignments 
from the previous module, followed by an overview of the 
content of the present module. Table 1 summarises the 
topics and content of each module.
Guidance
Within 2 weekdays after module completion, participants 
individually receive a semi-standardised feedback from a 
trained psychologist (e-coach). The supportive feedback 
focuses on participant’s entries and weekly assignments 
and aims to reinforce self-efficacy and adherence.57 
E-coaches will send reminders to inactive participants 
or in case of belated module completion. Participants 
are able to contact the assigned e-coach any time via the 
internet platform and vice versa. Communication runs 
exclusively on the internet platform. E-coaches are clin-
ical psychologists (undergraduate students, postgraduate 
clinical psychologists in psychotherapy training), who are 
trained beforehand and supervised regularly by experi-
enced, licensed psychotherapists (SH, MW).
Text messages
The web-based content will be extended by optional, moti-
vating text messages (SMS-coach). This includes regu-
larly sent automatic text messages, which are tailored to 
the intervention content. Previous trials have shown the 
augmenting effect of text messages on efficacy and adher-
ence.58 59 The messages include reminders to homework 
Table 1 Intervention content (based on Kleinstäuber et al50)
Module Content
1 Goal setting History of symptom 
development, goal setting
2 Stress education Psychoeducation on stress 
reaction, relaxation techniques
3 Attention control Attention shift, euthymic 
activities
4 Illness attitudes Cognitive modification, 
interoceptive exposure
5 Illness behaviour Activity training, reduction of 
avoidance or safety behaviour
6 Stress management Transactional stress model,117 
stress management techniques
7 Summary and 
planning
Biopsychosocial explanatory 
model, summarising personal 
coping strategies, relapse 
prevention
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or intervention use, tiny-tasks or reinforcement of moti-
vation to exercise.
Control condition
Participants in the WLCG have unrestricted access to 
usual treatment options. Eight weeks postrandomisa-
tion, the WLCG will receive iSOMA with written e-coach 
contact on demand through the intervention platform, as 
proven to be effective in previous trials.60 61
Assessments and outcomes
Assessments will be conducted at baseline (T0) after 
completion of the intervention follow-up (8 weeks, T1), 
respectively at 16 weeks follow-up (T2) for the WLCG. 
A list of outcomes and measurement instruments is 
presented in table 2. Eligibility criteria, outcomes, poten-
tial effect-modifying variables and demographics will 
be assessed via self-report with validated questionnaires 
(approximately 20–30 min per assessment). In case of 
non-compliance, up to three reminders will be sent via 
email within the week after invitation for the assessment, 
followed by contact via phone, after which participants 
will be characterised as non-completers. The instru-
ments will be provided using a separate, secure online 
survey platform ( www. unipark. de). All forms and data 
sets related to study data will be kept in locked cabinets. 
Study-related information will be stored securely in local, 
password-protected data files accessible only to the study 
team. Backups of the primary database (Unipark) will be 
performed weekly. Principal investigators will be given 
access to the processed data sets. Participant data will be 
identified by a coded identification number to maintain 
participant confidentiality. All reports will be prepared 
such that no individual subject can be identified. Figure 1 
shows the study flow chart and inclusion criteria.
Primary outcome: somatic symptom distress
As a well-established and economic instrument, the 
PHQ-1553 will be administered at each measurement 
Table 2 Outcome criteria, measurement instrument, assessment points
Outcome/variable Instrument
Assessment point
T0 T1 T2*
Primary outcome
  Somatic symptom distress PHQ-15 x x x
  Psychological and behavioural aspects of somatic symptom 
distress
SSD-12 x x x
Secondary outcome
  Depression PHQ-9 x x x
  Anxiety GAD-7 x x x
  Functioning PDI x x x
  Health anxiety mSHAI x x x
  Attitude towards face-to-face psychotherapy ATSPPH x x x
Covariates
  Demographics Web-based self-report x
  Healthcare utilisation Web-based self-report x x x
  Somatosensory amplification SSAS x
  Emotional reactivity ERS x
  Therapeutic alliance WAI-SR (x) †
  Attitudes and expectations towards iCBT CEQ x
  Intervention satisfaction CSQ-I x ‡ x
  Subjective negative intervention effects INEP x ‡ x
  Adherence Attrition/completion 
rates
x ‡ x
*Only for control group. 
†3 weeks after intervention start. 
‡Only for intervention group. 
T0, baseline; T1, 8 weeks postrandomisation; T2, 16 weeks postrandomisation; ATSPPH, Attitudes Towards Seeking Professional 
Psychological Help; GAD-7, Generalised Anxiety Disorder Questionnaire; INEP, Side Effects of Psychotherapy Inventory; 
mSHAI, modified short version of the Health Anxiety Inventory; PERS, Perth Emotion Reactivity Scale; PDI, Pain Disability Index; PHQ, Patient 
Health Questionnaire; SSAS, Somatosensory Amplification Scale; SSD-12, somatic symptom disorder—B Criteria Scale; WAI-SR, Working 
Alliance Inventory—short revised; CEQ, Credibility/Expectancy Questionnaire; CSQ-I, Client Satisfaction Questionnaire for internet-based 
interventions. 
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point. The PHQ-15 is a validated brief self-report 
screening for somatoform disorders,62 including the 
15 most typical somatic complaints in primary care.63 
Participants rate the somatic symptom burden within the 
preceding 4 weeks on a 3-point scale (0=‘not bothered at 
all’ to 2=‘bothered a lot’). The PHQ-15 has proven to be 
a reliable instrument (α=0.80).53
To account for the focus on dysfunctional psycho-
logical features of somatoform disorders as defined in 
the DSM-5, the recently developed Somatic Symptom 
Disorder Scale (SSD-12) was included.64 The scale consists 
of 12 items covering the frequency of cognitive, affective 
and behavioural aspects in association with bothersome 
somatic symptoms. Answers are rated on a 5-point scale 
(0=‘never’ to 4=‘very often’). The instrument proved to 
be highly reliable in a clinical outpatient (α=0.95)64 and 
in a population-based sample (α=0.95).65
Secondary outcomes
To account for the high degree of co-occurrence between 
somatic symptom distress and symptoms of general and 
health anxiety as well as depression,4 66 these clinical 
comorbidities will be assessed with self-report instruments. 
The severity of depressive symptoms will be assessed with 
the 9-item Patient Health Questionnaire (PHQ-9).67 The 
nine items cover the DSM-IV criteria for major depres-
sion. Furthermore, the seven-item Generalised Anxiety 
Disorder Questionnaire (GAD-7) will be included to 
evaluate the severity of anxiety. Both instruments feature 
4-point answer scales (0=‘not at all’ to 3=‘nearly every 
day’) and have proven to be valid screening and instru-
ments in population-based samples.68 69 As a distinct 
feature of somatic symptom disorders, health anxiety will 
be assessed with a modified, 14-item short version of the 
Health Anxiety Inventory.70 Items (eg, "I am sometimes 
afraid I have a serious illness") are rated on a 5-point scale 
(1=‘does not apply to me at all’ to 4=‘does totally apply to 
me’) and can be added to a total score, ranging from 0 
to 56. The adapted version (modified short version of the 
Health Anxiety Inventory, mSHAI) proved to be highly 
reliable in a student population (α=0.93).
The level of disability will be assessed with the German 
version71 of the Pain Disability Index (PDI).72 Partici-
pants rate the perceived disability on an 11-point scale 
(0=‘no interference’ to 10=‘total interference’) in seven 
items representing various domains of functioning (eg, 
social activities, occupation, self-care). The scale shows an 
internal consistency of α=0.86.73
Attitudes and expectations
The 10-item short form of the Attitudes Toward 
Seeking Professional Psychological Help questionnaire 
(ATSPPH)74 will be included. Answers on this scale are 
rated on a 4-point scale (0=‘disagree’ to 3=‘agree’). The 
items (eg, "I would want to get psychological help if I were 
worried or upset for a long period of time") can be added 
to a total score, ranging from 0 to 30. The ATSPPH shows 
a high reliability of α=0.84.
To study the association of treatment expectations and 
outcomes,75 the Credibility/Expectancy Questionnaire 
(CEQ)76 will be included. The questionnaire features 
six items (eg, "How successfully do you think this treat-
ment will be in reducing your symptoms?”). The answer 
scale for two items (from 0% to 100%) was adapted to 
correspond to the 9-point Likert scale of the remaining 
items. Higher scores indicate positive expectations and 
credibility. The CEQ has proven to be an easy-to-ad-
minister and reliable instrument (α=0.85)77 in clinical 
studies. Based on the previous literature on unfavourable 
attitudes of individuals with chronic somatic symptoms 
towards psychotherapy,78 we expect a positive influence 
of prior expectations on treatment outcomes as well as a 
positive change in attitudes towards psychotherapy in the 
prepost comparison.
Subjective side effects
Adverse events and side effects of the IMIs remain a less 
studied research field.79 Thus, adverse events during the 
intervention will be assessed with a 15-item version of 
the Side Effects of Psychotherapy Inventory (INEP)80 as 
used in previous trials.81 The items cover possible adverse 
effects on social, intrapersonal or work-related situa-
tions (eg, ‘worse/better relationship with family’). Six 
items are rated on a 7-point bipolar scale, the others on 
a 4-point Likert scale (0=‘no agreement at all’; 3=‘total 
agreement’). The original scale shows a high internal 
consistency of α=0.85. Furthermore, symptom deteriora-
tion will be assessed as a possible negative effect of the 
intervention under study.79
Therapeutic alliance
Previous evidence suggests comparable alliance ratings 
by participants of guided IMIs to patients in face-to-face 
psychotherapy.82 83 However, the association of perceived 
alliance and outcome remains inconclusive and the role 
of therapist’s alliance ratings is insufficiently studied.84 
Thus, in the present study, the therapeutic alliance will 
be assessed in the early intervention phase (3 weeks 
after intervention start) from participants and the asso-
ciated e-coach with an adapted version of the short form 
of the Working Alliance Inventory (WAI-SR)85 as used 
in previous trials.86 The WAI is based on Bordin’s three 
dimensions of working alliance87: agreement on thera-
peutic goals, consensus on tasks, affective bond between 
client and therapist, which are assessed in four items each 
and rated on a 5-point scale (1=‘never’ to 5=‘always’). The 
version for the participants in the contact on demand 
condition will be adapted based on a previous study88 to 
measure alliance with the self-help programme.
Intervention satisfaction and adherence
The postintervention satisfaction will be assessed with 
a translated version of the Client Satisfaction Question-
naire (CSQ), adapted to the context of IMIs.89 The self-re-
port questionnaire includes eight items that are rated 
on a 4-point scale (1=‘does not apply to me’ to 4=‘does 
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totally apply to me’). The adapted version proved to be 
highly reliable (McDonald’s ω=0.95).89 Furthermore, 
acceptance of the intervention modules will be analysed 
using free feedback forms. Participant adherence to the 
intervention is assessed by the proportion of sessions 
completed during the intervention period and the total 
length (minutes) of the intervention exposure during the 
intervention period. Reasons for attrition will be assessed 
via email.
Covariates
Since previous research has demonstrated an effect-mod-
ifying influence of several demographic, clinical or inter-
net-oriented variables,90 the following covariates will be 
assessed: demographic variables (eg, age, gender, field of 
study), medical variables (eg, prior treatments, somatic/
mental diagnoses, current healthcare utilisation). 
Furthermore, we will assess the influence of somatosen-
sory amplification, the tendency to experience somatic 
sensations as intense, noxious or disturbing91 with the 
10-item German version of the Somatosensory Amplifica-
tion Scale (SSAS)92 as well as emotional reactivity, since 
somatisation has been associated with deficits in emotion 
regulation93 with a recently translated version of the Perth 
Emotion Reactivity Scale (PERS),94 including 30 items.
sample size estimation
The estimation of the necessary sample size was based on 
power calculations and evidence from previous studies. 
The effect sizes of interventions for persistent somatic 
symptoms have a wide range and depend on the condi-
tion of intervention, that is, somatic symptom reduction 
in functional somatoform syndromes in guided iCBT 
with effect sizes from d=0.1095 to d=1.21,96 aggregated 
effect sizes of self-help interventions in general (Hedge’s 
g=0.58)15 or of face-to-face CBT (d=0.38).12 Based on these 
findings, a moderate effect size of d=0.50 is expected. A 
power analysis for the group comparison iSOMA versus 
WLCG using analysis of covariance (ANCOVA) with base-
line scores as covariates, an α error of 0.05 and a power 
of β=0.80 showed that a sample size of n=128 is required. 
Considering attrition rates of previous trials, for example, 
in functional somatic syndromes,97 chronic pain98 or 
various chronic health conditions99 as well as recent trials 
in the relevant target group of university students,29 a 
drop-out rate of 20% is expected for the current trial, 
resulting in a necessary sample size of n=154 (n=77 per 
group). The estimated sample size is suitable regarding 
prevalence rates of the somatoform syndrome45 and 
somatoform disorders in German university students.46
Ethics and dissemination
The methods described in this study protocol have 
been approved by the ethics committee of the Insti-
tute of Psychology of the University of Mainz (Ref. Nr. 
2017-JGU-psychEK-012). Protocol modifications are 
subject to the ethics committee’s approval and will be 
indicated in the trial registration. Results from this study 
will be published in peer-reviewed journals and presented 
at international conferences. Participant-friendly summa-
ries of trial findings will be published on the project’s 
website.
Before allocation to the trial, individuals receive detailed 
information about the nature, purpose and possible 
consequences of the trial. Participants are informed that 
the intervention under study does not replace medical 
and or psychotherapeutic treatment. Participants are 
required to give a written informed consent to participate 
in the study (model study information and consent form 
available on request).
Based on previous, similar trials, a very low risk of 
adverse events is expected.100 101 However, participants 
are able to contact the study team during working hours. 
Beyond that, participants are referred to a nation-wide 
and 24×7 telephone crisis hotline and receive detailed 
information about treatment options. If participants of 
both study arms indicate suicidal ideation in the Beck 
Depression Inventory-II (BDI-II)102 or within the inter-
vention, a standardised suicide protocol adapted from 
previous trials in depressive populations55 103 will be 
applied. Participants are required to indicate their tele-
phone number for emergency contact. (1) Participants 
who report a low level of suicidal ideation (BDI-II item 
score=1) will receive information with psychoeducation, 
information on health services via email and will be 
advised to seek professional help in case of symptom dete-
rioration. (2) Participants with a moderate BDI-II item 
score (=2) additionally will receive a non-suicide contract 
and access to a separate web-based lecture on suicidality, 
where they will be guided in filling out an individual crisis 
plan and develop coping mechanisms.104 (3) If high levels 
of suicidal ideation are reported (BDI-II item score=3), 
participants will be contacted by phone by one of the 
supervisors (SH, MW) for risk assessment and to initiate 
further actions (eg, information, non-suicide contract, 
crisis plan, treatment options).
statistical analyses
Intention-to-treat (ITT) samples will be analysed. Addi-
tional per-protocol analyses will be conducted to examine 
the influence of attrition on outcomes. No interim anal-
yses will be conducted on the primary end point. Primary 
and secondary outcomes will be analysed as continuous 
variables (eg, sum scores). The primary and secondary 
outcomes at follow-up (T1, T2) will be analysed with 
ANCOVA, controlling for the baseline measurement (T0) 
and empirically identified covariates (significant zero-
order correlations with the primary outcome) according 
to recommendations by Vickers and Altman.105 Multiple 
regression models will be used to test potential medi-
ating or moderating effects (eg, somatosensory amplifi-
cation, emotional reactivity and therapeutic alliance). 
Additionally, to investigate the number of participants 
attaining a reliable improvement in the primary outcome 
measurement, scores will be characterised as responders, 
non-clinically changed or non-responders according 
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to the reliable change index.106 Strategies for replacing 
missing data will be evaluated after the amount and 
pattern of missing data has been investigated. Subgroup 
analyses will be conducted after relevant characteristics 
of the final study sample have been investigated. Charac-
teristics of dropouts at follow-up will be compared with 
responders. All analyses will be conducted on a two-sided 
level of significance (α=0.05).
dIsCussIon
To the best our knowledge, the proposed study is the first 
to investigate the efficacy of a CBT-based online interven-
tion in an academic context for somatic symptoms and 
related distress. University students represent a highly 
relevant target group for preventive interventions since 
subclinical somatic syndromes are common45 and have 
been associated with serious clinical, occupational and 
societal consequences.4 5 107 Furthermore, the evidence 
points to an undertreatment of this at-risk group.17 107 
Since internet usage and acceptance of web-based health 
promotion is high in university students,25 107 a web-based 
approach such as the studicare-framework represents an 
easy-accessible, international hub for low-threshold treat-
ment options for various somatic and mental health issues. 
A recent trial investigating an IMI for stress in university 
students, for example, found that 77% of participants 
were first-time help-seekers.30 Therefore, the intervention 
under study represents a promising approach to prevent 
and to treat somatic symptoms and related distress on a 
public health level.
However, in conducting this trial, several challenges 
are expected and will be addressed as mentioned below.
First, to allow for low-threshold access, inclusion 
criteria will comprise somatic symptoms irrespective 
of their primary cause (physical or psychological), 
following the DSM-5 classification of SSD. Although the 
expected clinical diversity is welcome to test the gener-
alisability of iSOMA as a transdiagnostic intervention, 
heterogeneity needs to be considered in further anal-
yses. Therefore, subgroup analyses will be performed 
to differentiate the sample characteristics and evaluate 
a potential effect-modulating influence of comorbid 
somatic disorders.
Second, moderate-to-high drop-out rates have been 
reported for IMIs, that is, 4%96 to 38%108 in guided 
iCBT of IBS. Dropout may even be more pronounced in 
preventive oriented trials. The literature points to various 
risk factors for dropout,109–111 which were addressed 
in the development of iSOMA and the research design 
such as a short intervention duration (8 weeks), avail-
ability of guidance (e-coach, SMS-coach),28 112 reminders 
in case of inactivity58 and interactivity and variability of 
the intervention content (eg, multimedia-based, respon-
sive design).113 However, it needs to be considered that a 
reduced treatment adherence is not necessarily an indi-
cator of limited effectiveness, but can also express early 
recovery. Thus, we attempt to assess the reasons for and 
timing of dropout in the present study.
Third, individuals with chronic somatic symptoms 
tend to develop somatically dominated models for their 
symptoms and thus may hold negative attitudes towards 
mental health interventions,19 21 which could have 
implications for the accessibility of the intervention 
under study. Therefore, the intervention rationale50 
features a primarily somatic-oriented entrance and a 
gradual development of a multicausal psychobiological 
explanatory model instead of an immediate introduc-
tion (table 1).
Previous trials focused on functional somatic syndromes 
or chronic pain,32 33 which leaves polysymptomatic 
conditions under-represented in research yet. However, 
international epidemiological studies show that somatic 
symptoms typically do not occur singularly but across 
multiple body systems.114 115 Therefore, the current trial 
features a transdiagnostic approach considering the 
interplay of physiological and psychological symptoms in 
various clinical conditions. The strong theoretical foun-
dation of intervention allows for directly targeting central 
dysfunctional mechanisms of the somatic syndrome. 
Thus, a higher effectiveness in comparison to non-man-
ualised IMIs can be expected.116 Further distinct features 
of the intervention include the adaption of behavioural 
experiments and interoceptive exposure, which have 
been shown to be effective intervention components in 
IMIs.37 96 Further strengths of this study include a rigorous 
methodical quality, including an ITT analysis, which 
prevents overestimation of the intervention’s effective-
ness. Also, various diagnostic instruments will be included 
to investigate possible moderators and mediators with a 
focus on psychopathological mechanisms, therapeutic 
alliance and potential side effects. In the future, this 
allows for a differentiated indication and identification 
of risk groups. Thus, the study results will have extensive 
implications for researchers, health professionals and 
academic mental healthcare.
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